雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Bone and Cartilage Diseases and Regeneration. Cartilage repair and regenerative medicine;past, present, and future. Mera Hisashi 1 , Itokazu Maki 2 , Wakitani Shigeyuki 3 1Department of Health and Sports Sciences, Mukogawa Women's University, Nishinomiya, Japan. 2Department of Health and Sports Sciences, Mukogawa Women's University, Nishinomiya, Japan./Department of Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan. 3Department of Health and Sports Sciences, Mukogawa Women's University, Nishinomiya, Japan. pp.1715-1722
Published Date 2013/11/28
DOI https://doi.org/10.20837/4201312023
  • Abstract
  • Look Inside
  • Reference

 Since the days of ancient Greece, it has been known that articular cartilage has poor potential to repair.In April, 2013, autologous chondrocyte implantation(ACI)was approved by the Japanese ministry of Health, Labour and Welfare, as the first orthopedic cell therapy in Japan. Half a century has passed since Chesterman's report on rabbit allogeneic chondrocyte implantation, and approximately 20 years since the first human ACI report by Brittberg. In Japan, 24 years has passed since Wakitani's allogeneic chondrocyte implantation, and over 10 years since the human ACI report by Ochi. A long-term follow-up clinical trial with the high statistical power is needed to verify the safety and efficacy of new cartilage joint therapy. Moreover, we need the infrastructure, including drug and/or device regulation and timely approved by the government, to apply new therapies in similar time frames to other developed nations.



基本情報

電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有